Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-09 Sale | 2023-01-11 8:30 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 14,096 | $1.111 | $15,661 | 66,018 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 8:56 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 12,817 | $6.883 | $88,220 | 52,614 (Direct) | View |
| 2021-01-20 Sale | 2021-01-22 6:35 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 30,000 | $11.36 | $340,786 | 458,990 (Direct) | View |
| 2021-01-07 Sale | 2021-01-11 06:19 am | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 5,827 | $6.8889 | $40,142 | 55,881 (Direct) | View |
| 2020-09-01 Sale | 2020-09-02 6:05 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 7,200 | $8.06 | $58,032 | 61,708 (Direct) | View |
| 2020-08-14 Sale | 2020-08-18 8:31 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 2,182 | $4.7096 | $10,276 | 68,908 (Direct) | View |
| 2020-01-07 Sale | 2020-01-10 08:54 am | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 2,624 | $7.78 | $20,415 | 44,390 (Direct) | View |
| 2019-08-14 Sale | 2019-08-16 8:58 pm | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 2,336 | $3.9938 | $9,330 | 47,014 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-21 Option Award | 2024-03-25 8:39 pm | N/A 2034-03-20 | LENZ Therapeutics Inc. | LENZ | Drapkin Kimberlee C Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2023-07-28 Option Award | 2023-08-01 8:09 pm | N/A 2033-07-27 | Graphite Bio Inc. | GRPH | Drapkin Kimberlee C Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-07-01 Option Award | 2023-07-05 4:18 pm | N/A 2033-06-30 | KINETA INC. | KA | Drapkin Kimberlee C Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-07 5:40 pm | N/A 2033-06-05 | Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2023-05-03 Disposition | 2023-05-04 07:43 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C President, CFO and Treasurer | 586,270 | $0 | 0 (Direct) | View |
| 2023-05-03 Equity Swap | 2023-05-04 07:43 am | N/A N/A | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C President, CFO and Treasurer | 66,018 | $0 | 0 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 4:22 pm | N/A 2032-06-14 | Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-04-01 Option Award | 2022-04-04 5:11 pm | N/A 2032-04-01 | Acumen Pharmaceuticals Inc. | ABOS | Drapkin Kimberlee C Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 7:38 pm | N/A 2032-02-01 | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 82,500 | $0 | 135,114 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:05 pm | N/A 2031-06-01 | YUMANITY THERAPEUTICS INC. | YMTX | Drapkin Kimberlee C Director | 14,800 | $0 | 14,800 (Direct) | View |
| 2021-02-01 Option Award | 2021-02-03 5:46 pm | N/A 2031-02-01 | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 66,750 | $0 | 109,931 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-22 6:35 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 7,509 | $2.36 | 458,990 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-22 6:35 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 3,016 | $0.48 | 458,990 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-22 6:35 pm | N/A 2024-01-27 | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 17,300 | $0 | 458,990 (Direct) | View |
| 2021-01-20 Exercise | 2021-01-22 6:35 pm | N/A N/A | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 6,775 | $0.74 | 458,990 (Direct) | View |
| 2020-06-29 Option Award | 2020-07-01 5:24 pm | N/A 2030-06-29 | PROTEOSTASIS THERAPEUTICS INC. | PTI | Drapkin Kimberlee C Director | 17,400 | $0 | 17,400 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-04 9:00 pm | N/A 2030-02-03 | Jounce Therapeutics Inc. | JNCE | Drapkin Kimberlee C CFO and Treasurer | 80,100 | $0 | 124,490 (Direct) | View |